, Volume 131, Issue 1, pp 33-39
Date: 07 Jul 2011

Common variants for atrial fibrillation: results from genome-wide association studies

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Atrial fibrillation (AF) affects more than 5 million people worldwide; however, none of the anti-arrhythmic drugs available now are entirely optimal in terms of efficacy and safety. A better understanding of the molecular mechanism of AF will facilitate the process of finding new strategies to prevent AF. As the non-familial AF is the major form of AF, identifying common variants for AF in these populations by genome-wide association studies will definitely accelerate this process. This review summarizes the recently identified common AF variants on 4q25, 16q22, and 1q21 and discusses their implications for the clinic.